13F Holdings
中文EN

ACHC Acadia Healthcare Company, Inc.

Services-Specialty Outpatient Facilities, NEC · Nasdaq · SEC CIK 1520697 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY4.5%
TTM net income YoY-1,150.7%
TTM EPS YoY-1,154.2%
Revenue 3-yr CAGR6.0%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin-33.1%
FCF margin-0.7%
EBITDA margin—

Returns

ROE-43.9%
ROA-18.9%
ROIC (approx.)—
Asset turnover0.57x

Leverage & solvency

Liabilities / assets59.5%
Debt / equity1.16x
Current ratio1.60x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.21x
Accruals ratio-22.8%
Payout ratio—
Capex / revenue7.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$3.31B$3.15B$2.93B$2.61B$2.31B
SG&A expense$177.60M$156.80M$153.30M$124.30M$108.20M
Pretax income-$1.07B$341.88M-$25.36M$374.14M$275.76M
Income tax$25.98M$77.39M-$9.70M$94.11M$67.56M
Net income-$1.10B$255.61M-$21.67M$273.14M$190.63M
EPS (basic)-12.162.79-0.243.052.15
EPS (diluted)-12.162.78-0.242.982.10
Weighted avg. shares (diluted)90.70M92.06M90.95M91.56M90.79M
Banking
Net interest income-$138.86M-$116.37M-$82.12M-$69.76M-$76.99M
Balance sheet
Cash & equivalents$133.24M$76.31M$100.07M$97.65M$133.81M
Receivables$440.60M$365.34M$361.45M$322.44M$281.33M
Inventory$5.69M$5.65M$5.30M$5.09M$4.79M
Current assets$814.14M$577.49M$596.00M$506.12M$495.03M
PP&E, net$3.11B$2.85B$2.27B$1.95B$1.77B
Goodwill$1.30B$2.26B$2.23B$2.22B$2.20B
Intangibles$96.67M$70.00M$73.28M$76.04M$70.14M
Total assets$5.53B$5.96B$5.36B$4.99B$4.77B
Current liabilities$525.19M$577.92M$885.78M$388.33M$404.86M
Short-term debt$28.44M$76.82M$29.22M$21.25M$18.59M
Long-term debt$2.47B$1.88B$1.34B$1.36B$1.48B
Total debt$2.50B$1.96B$1.37B$1.39B$1.50B
Total liabilities$3.39B$2.77B$2.47B$2.09B$2.19B
Shareholders' equity$1.95B$3.07B$2.78B$2.81B$2.52B
Net debt$2.37B$1.88B$1.27B$1.29B$1.36B
Shares outstanding90.45M91.78M91.26M89.91M89.03M
Cash flow statement
Operating cash flow$131.90M$129.69M$462.34M$380.57M$374.48M
Capital expenditure$571.81M$690.38M$424.13M$296.15M$244.81M
Free cash flow-$439.91M-$560.69M$38.21M$84.42M$129.67M
Investing cash flow-$556.21M-$736.48M-$397.22M-$305.83M$1.01B
Financing cash flow$481.25M$583.02M-$62.70M-$110.90M-$1.64B
Depreciation & amortization$189.25M$149.59M$132.35M$117.77M$106.72M
Stock-based compensation$31.71M$37.11M$32.29M$29.64M$37.53M
Share buybacks$50.03M————

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.